Effect of morphine on lipopolysaccharide-induced tumor necrosis factor-alpha production in vivo: Involvement of the sympathetic nervous system

被引:50
作者
Bencsics, A
Elenkov, IJ
Vizi, ES
机构
[1] HUNGARIAN ACAD SCI,INST EXPT MED,H-1450 BUDAPEST,HUNGARY
[2] NICHHD,DEV ENDOCRINOL BRANCH,NIH,BETHESDA,MD 20892
[3] NIAMSD,ARTHRIT & RHEUMATISM BRANCH,NIH,BETHESDA,MD 20892
基金
匈牙利科学研究基金会;
关键词
morphine; opioid receptors; lipopolysaccharide; tumor necrosis factor alpha; sympathetic nervous system; norepinephrine; neuroimmunomodulation; in vivo;
D O I
10.1016/S0165-5728(96)00163-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Morphine treatment modulates a variety of immunological parameters, including tumor necrosis factor-alpha (TNF-alpha) production by activated macrophages in vitro. The aim of our study was to clarify the effect of morphine on lipopolysaccharide (LPS)-induced TNF-alpha production in vivo. Plasma TNF-alpha levels of mice were determined by ELISA. Subcutaneous injection of morphine decreased LPS-induced TNF-alpha production throughout the response, an effect that was dose-dependent and reversible by naloxone. Blockade of the sympathetic transmission by chlorisondamine prevented the inhibitory effect of morphine on TNF-alpha production. It is concluded that (i) systemic administration of morphine inhibits LPS-induced TNF-alpha production in vivo via 'classic' opioid receptors; (ii) this effect requires intact sympathetic outflow. Since the increased incidence of bacterial and viral infections in opioid addicts is well documented, it is suggested that the inhibitory effect of morphine on TNF-alpha production might play a substantial role in the increased vulnerability of these individuals to certain infections.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 44 条
[1]   HYPOTHALAMIC OPIOID PEPTIDE REGULATION OF CATECHOLAMINE SECRETION [J].
APPEL, NM ;
KIRITSYROY, JA ;
VANLOON, GR .
NEUROPEPTIDES, 1984, 5 (1-3) :287-290
[2]   MU-RECEPTORS AT DISCRETE HYPOTHALAMIC AND BRAIN-STEM SITES MEDIATE OPIOID PEPTIDE-INDUCED INCREASES IN CENTRAL SYMPATHETIC OUTFLOW [J].
APPEL, NM ;
KIRITSYROY, JA ;
VANLOON, GR .
BRAIN RESEARCH, 1986, 378 (01) :8-20
[3]   OPIATES, MAST-CELLS AND HISTAMINE-RELEASE [J].
BARKE, KE ;
HOUGH, LB .
LIFE SCIENCES, 1993, 53 (18) :1391-1399
[4]  
BELKOWSKI SM, 1995, J PHARMACOL EXP THER, V273, P1491
[5]  
BEUTLER B, 1995, J INVEST MED, V43, P227
[6]   CONTROL OF CACHECTIN (TUMOR-NECROSIS-FACTOR) SYNTHESIS - MECHANISMS OF ENDOTOXIN RESISTANCE [J].
BEUTLER, B ;
KROCHIN, N ;
MILSARK, IW ;
LUEDKE, C ;
CERAMI, A .
SCIENCE, 1986, 232 (4753) :977-980
[7]  
BRYANT HU, 1990, J PHARMACOL EXP THER, V255, P410
[8]   OPIOID RECEPTORS ON CELLS OF THE IMMUNE-SYSTEM - EVIDENCE FOR DELTA-CLASS AND KAPPA-CLASS [J].
CARR, DJJ ;
DECOSTA, BR ;
KIM, CH ;
JACOBSON, AE ;
GUARCELLO, V ;
RICE, KC ;
BLALOCK, JE .
JOURNAL OF ENDOCRINOLOGY, 1989, 122 (01) :161-168
[9]  
CARR DJJ, 1991, P SOC EXP BIOL MED, V198, P710
[10]   MORPHINE INHIBITS THE RELEASE OF TUMOR-NECROSIS-FACTOR IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR CELL-CULTURES [J].
CHAO, CC ;
MOLITOR, TW ;
CLOSE, K ;
HU, SX ;
PETERSON, PK .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1993, 15 (03) :447-453